PRF Technologies (PRFX) Net Income (QoQ) (2020 - 2024)
PRF Technologies (PRFX) Net Income (QoQ) (2020 - 2024) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 44.51 Bn | 43.55 Bn | - |
| 2 | Teva Pharmaceutical Industries | 43.52 Bn | 39.86 Bn | 2.15 Bn |
| 3 | Zoetis | 32.43 Bn | 30.75 Bn | 1.05 Bn |
| 4 | Takeda Pharmaceutical | 28.63 Bn | 22.83 Bn | 5.10 Bn |
| 5 | United Therapeutics | 21.87 Bn | 19.21 Bn | 683.80 Mn |
| 6 | Viatris | 18.98 Bn | 18.09 Bn | 1.46 Bn |
| 7 | Neurocrine Biosciences | 15.43 Bn | 15.04 Bn | 935.80 Mn |
| 8 | Elanco Animal Health | 12.02 Bn | 11.49 Bn | 798.00 Mn |
| 9 | Dr Reddys Laboratories | 10.14 Bn | 9.98 Bn | - |
| 10 | PRF Technologies | 647,973.00 | -3.49 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2024 | 196.64% |
| Mar 31, 2024 | 48.73% |
| Dec 31, 2023 | -29,933.33% |
| Sep 30, 2023 | 100.53% |
| Jun 30, 2023 | -394.50% |
| Mar 31, 2023 | 126.01% |
| Dec 31, 2022 | -520.82% |
| Sep 30, 2022 | -59.53% |
| Jun 30, 2022 | 407.62% |
| Mar 31, 2022 | 75.42% |
| Dec 31, 2021 | -174.48% |
| Sep 30, 2021 | 644.09% |
| Jun 30, 2021 | 16.66% |
| Mar 31, 2021 | 51.02% |
| Dec 31, 2020 | 16.91% |
| Sep 30, 2020 | -851.87% |
| Jun 30, 2020 | -48.53% |